Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
SUPPLEMENT ARTICLE

Evolution of the Pediatric Influenza Vaccination Program in the United States

Kathleen M. Neuzil, Anthony E. Fiore and Richard A. Schieber
Pediatrics March 2012, 129 (Supplement 2) S51-S53; DOI: https://doi.org/10.1542/peds.2011-0737B
Kathleen M. Neuzil
aPATH and University of Washington School of Medicine, Seattle, Washington; and
bPast Chair, Advisory Committee on Immunization Practices Influenza Work Group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony E. Fiore
cInfluenza Division, National Center for Immunization and Respiratory Diseases; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard A. Schieber
dEpidemiology and Analysis Program Office, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • Comments
Loading
Download PDF
  • Abbreviations:
    ACIP —
    Advisory Committee on Immunization Practices
    CDC —
    Centers for Disease Control and Prevention
    SLV —
    school-located mass vaccination
    TIV —
    trivalent influenza vaccine
  • For many years, the Advisory Committee on Immunization Practices (ACIP) for the Centers for Disease Control and Prevention (CDC) focused its vaccination policy on persons at higher risk for influenza complications (eg, older adults, children and adults with certain high-risk conditions, pregnant women) and their contacts (eg, household contacts, health care personnel). Unfortunately, although vaccination coverage rates varied, they remained low for most adult and pediatric high-risk groups, other than persons aged ≥65 years.1 In conjunction with the recognition that influenza vaccination recommendations for high-risk target populations were not being optimally implemented, the adverse effects of influenza illness on all children was increasingly recognized. This led to the expansion of vaccination recommendations for children, beginning in 2002, when influenza vaccination was “encouraged” for children aged 6 through 23 months, and in 2004, when a full recommendation was issued for this age group.2,3 That recommendation was based largely on studies documenting that these young children had influenza-related hospitalization rates that were comparable to hospitalization rates in older persons with underlying risk conditions who were targeted to receive influenza vaccine.4–6 Full recommendation was added for other groups who are at risk, such as adults and children with neuromuscular and other conditions that can compromise respiratory function or the handling of respiratory secretions, as data became available.7

    The gradual, incremental, group-by-group expansion of influenza recommendations to additional age and risk groups was challenging for providers and the public. In the ensuing years, immunization experts, professional organizations, and other stakeholders debated the advantages and challenges of expanding routine influenza vaccination to all persons in the United States.8–10 At a meeting of immunization and public health experts in October 2005, participants reviewed data on vaccine safety and effectiveness, burden of illness, cost-effectiveness, the potential for indirect protection, and feasibility.11 Although most meeting attendees supported the concept of universal vaccination, they still favored an incremental approach, beginning first with expansion among children. They reasoned that vaccination of children would yield direct benefits in the reduction of disease burden among vaccinees, given the high influenza attack rates among this age group and the demonstrated efficacy of the vaccine. In addition, the potential for decreased transmission and disease reduction in contacts of children and the broader community was cited. Implementation concerns were acknowledged, including concerns about potentially insufficient vaccine supply.11

    In February 2006, the ACIP expanded its influenza vaccination recommendations to include all children aged 2 years through 4 years (24 months through 59 months), on the basis of accumulating evidence that children in this age group also had substantial morbidity from influenza.12 Although hospitalization rates among toddlers and preschool children were lower than rates among younger infants and children, rates of emergency department visits, outpatient visits, and antibiotic use in this age bracket were still higher than that of older children and were viewed as a substantial vaccine-preventable illness burden.6

    Even as these new recommendations were being implemented, some experts were considering the advantages and disadvantages of a universal pediatric influenza vaccination recommendation for children aged ≥6 months or older.6,8–10 A consultation jointly sponsored by the CDC and the Council of State and Territorial Epidemiologists was held in 2007. The meeting reviewed updated information on safety and effectiveness of the vaccine, cost-effectiveness, program implementation, and vaccine supply. The experience from several large influenza vaccination campaigns among this age group in several US states, as well as the experience with the universal campaign in the Ontario province of Canada, were reported and discussed.12,13 Although most attendees favored an expansion of influenza vaccination recommendations to older children, they acknowledged the daunting logistical challenges.13

    In 2008, after discussion at several public meetings and hearing the summary of the 2007 consultation, ACIP members voted unanimously that all children aged ≥6 months should receive influenza vaccine annually.14 With these recommendations, the United States become the first country in the world to endorse a universal pediatric influenza vaccination policy. The American Academy of Pediatrics and the American Academy of Family Physicians also have endorsed a universal pediatric influenza vaccination policy.15,16

    Ultimately, ACIP’s decision to expand the recommendation to all children was based primarily on the expected direct benefits to the vaccinees. For school-age children and their contacts, influenza illness has substantial adverse health effects and impact on the family, including increased antibiotic use, medical care visits, school absenteeism, and parental work loss. At the same time, the influenza vaccine was recognized to be effective and safe for school-age children. Additional impetus for the recommendation was the expectation that a simple age-based influenza vaccination recommendation would improve the existing low vaccine coverage levels among the ∼50% of school-age children who already had a risk- or contact-based indication for annual influenza vaccination. The potential reduction of influenza among household contacts of vaccinated children and the potential reduced disease rate within the broader community were discussed by the ACIP but were considered to be less important than the direct benefit to the vaccinated child when considering a new vaccination recommendation.14

    The main obstacle to the ACIP making a universal pediatric recommendation was whether a yearly vaccination for all children was feasible. The supply of influenza vaccine had been steadily increasing in the United States during the years before this recommendation, but concerns about local distribution issues were acknowledged. Vaccinating children would be particularly challenging, given that two doses are recommended for children aged <9 years the first year they are vaccinated. However, the ACIP concluded that, in the end, comprehensive efforts to vaccinate all children were not likely to be made until a recommendation was made.

    School-located vaccination (SLV) clinics are mass vaccination immunization clinics held on a preestablished day at a designated school for children who have prior informed consent signed by a parent or guardian. Before the 2009 H1N1 influenza pandemic, such programs had been developed in relatively few counties and school districts around the country. SLV clinics have recently been suggested as a promising mechanism of addressing the challenges of delivering vaccine to a large number of children over the course of a few months on an annual basis.

    This special supplement of Pediatrics was developed to provide a single source of information on the many facets of an SLV program. Articles included in this supplement discuss the following topics: current published data concerning influenza, influenza vaccine, and vaccination of children13; the feasibility of such programs and the wide range of vaccination coverage rates achieved at different sites17,18; methods of planning, clinic management, and responses to difficulties encountered19–21; attitudes of general pediatricians toward SLVs22; the potential role of volunteers at clinics18 debates by experts concerning the advantages and challenges of SLVs13;and proposed research to determine the impact of vaccinating school children.23

    Implementing the universal pediatric recommendation has faced challenges. In addition to the anticipated difficulties discussed earlier, the 2009 influenza A (H1N1) pandemic occurred in the same year as the first year of full implementation of the universal recommendation for annual influenza vaccination of children. Children were among the 5 initial target groups for 2009 H1N1 influenza monovalent vaccination efforts, and practitioners were faced with the daunting task of delivering 2 influenza vaccines—the trivalent seasonal and the influenza A (H1N1) 2009 monovalent vaccine—to this population.24 However, despite these challenges, the seasonal and pandemic influenza programs in children were remarkably successful. Among children aged 6 months through 17 years, national seasonal influenza vaccination coverage during 2009–2010 was higher than the previous year, and both the seasonal and monovalent pandemic vaccination coverage were higher than coverage for adults aged ≥18 years.25 Finding resources will be necessary to continue to ensure that influenza vaccination coverage levels can be improved and sustained.26 Using lessons learned from the pandemic experience will be important in shaping future pediatric vaccination programs.

    Footnotes

      • Accepted November 29, 2011.
    • Address correspondence to Richard Schieber, MD, MPH, Epidemiology and Analysis Program Office, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS E33, Atlanta, GA 30333. E-mail: rschieber{at}cdc.gov
    • The 3 authors made substantive intellectual contributions to this published study and met the following criteria: (1) made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; (2) drafted the article or revising it critically for important intellectual content; and (3) approved its final version to be published.

    • FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.

    References

    1. ↵
      1. Centers for Disease Control and Prevention
      . Influenza vaccination coverage among children and adults—United States, 2008-09 influenza season. MMWR Morb Mortal Wkly Rep. 2009;58(39):1091–1095pmid:19816396
      OpenUrlPubMed
    2. ↵
      Bridges CB, Harper SA, Fukuda K, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2003;52(RR-8):1–34
    3. ↵
      1. Harper SA,
      2. Fukuda K,
      3. Uyeki TM,
      4. Cox NJ,
      5. Bridges CB,
      6. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP)
      . Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004;53(RR-6):1–40pmid:15163927
      OpenUrlPubMed
    4. ↵
      1. Izurieta HS,
      2. Thompson WW,
      3. Kramarz P,
      4. et al
      . Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232–239pmid:10648764
      OpenUrlCrossRefPubMed
      1. Neuzil KM,
      2. Mellen BG,
      3. Wright PF,
      4. Mitchel EF Jr,
      5. Griffin MR
      . The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342(4):225–231pmid:10648763
      OpenUrlCrossRefPubMed
    5. ↵
      1. Poehling KA,
      2. Edwards KM,
      3. Weinberg GA,
      4. et al.,
      5. New Vaccine Surveillance Network
      . The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31–40pmid:16822994
      OpenUrlCrossRefPubMed
    6. ↵
      1. Harper SA,
      2. Fukuda K,
      3. Uyeki TM,
      4. Cox NJ,
      5. Bridges CB,
      6. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention
      . Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54(RR-8):1–40pmid:16086456
      OpenUrlPubMed
    7. ↵
      1. Abramson JS,
      2. Neuzil KM,
      3. Tamblyn SE
      . Annual universal influenza vaccination: ready or not? Clin Infect Dis. 2006;42(1):132–135pmid:16323103
      OpenUrlCrossRefPubMed
      1. Edwards KM,
      2. Griffin MR
      . Influenza vaccination of children: can it be accomplished? J Infect Dis. 2006;194(8):1027–1029pmid:16991075
      OpenUrlFREE Full Text
    8. ↵
      1. Glezen WP
      . Herd protection against influenza. J Clin Virol. 2006;37(4):237–243pmid:17008123
      OpenUrlCrossRefPubMed
    9. ↵
      1. Schwartz B,
      2. Hinman A,
      3. Abramson J,
      4. et al
      . Universal influenza vaccination in the United States: are we ready? Report of a meeting. J Infect Dis. 2006;194(suppl 2):S147–S154pmid:17163388
      OpenUrlAbstract/FREE Full Text
    10. ↵
      Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006;55(RR-10):1–42
    11. ↵
      1. Fiore AE,
      2. Epperson S,
      3. Perrotta D,
      4. Bernstein H,
      5. Neuzil K
      . Expanding the recommendations for annual influenza vaccination to school-age children in the United States. Pediatrics. 2012;129(suppl 2):S54–S62
    12. ↵
      1. Fiore AE,
      2. Shay DK,
      3. Broder K,
      4. et al.,
      5. Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices
      . Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008;57(RR-7):1–60pmid:18685555
      OpenUrlPubMed
    13. ↵
      1. Centers for Disease Control and Prevention
      . Recommended immunization schedules for persons aged 0 through 18 Years—United States, 2009. MMWR Morb Mortal Wkly Rep. 2009;57(46):Q1–Q4
      OpenUrl
    14. ↵
      1. American Academy of Pediatrics
      . Influenza. In: Pickering LK, ed. Red Book: 2009 Report of the Committee on Infectious Diseaes, 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:400–412
    15. ↵
      1. Schieber RA,
      2. Kennedy A,
      3. Kahn EB
      . Early experience conducting school-located vaccination programs for seasonal influenza. Pediatrics. 2012;129(suppl 2):S68–S74
    16. ↵
      1. Cummings GE,
      2. Ruff E,
      3. Guthrie SH,
      4. Hoffmaster MA,
      5. Leitch LL,
      6. King JC Jr
      . Successful use of volunteers to conduct school-located mass influenza vaccination clinics. Pediatrics. 2012;129(suppl 2):S88–S95
    17. ↵
      1. Fishbane M,
      2. Kist A,
      3. Schieber RA
      . Use of the emergency incident command system for school-located mass influenza vaccination clinics. Pediatrics. 2012;129(suppl 2):S101–S106
      1. Lott J,
      2. Johnson J
      . Promising practices for school-located vaccination clinics—Part I: preparation. Pediatrics. 2012;129(suppl 2):S75–S80
    18. ↵
      1. Lott J,
      2. Johnson J
      . Promising practices for school-located vaccination clinics—Part II: clinic operations and program sustainability. Pediatrics. 2012;129(suppl 2):S81–S87
    19. ↵
      1. Keane VA,
      2. Hudson AR,
      3. King JC Jr
      . Pediatrician attitudes concerning school-located vaccination clinics for seasonal influenza. Pediatrics. 2012;129(suppl 2):S96–S100pmid:10545546
      OpenUrlAbstract/FREE Full Text
    20. ↵
      1. Longini IM Jr
      . A theoretic framework to consider the effect of immunizing schoolchildren against influenza: implications for research. Pediatrics. 2012;129(suppl 2):S63–S67
    21. ↵
      1. National Center for Immunization and Respiratory Diseases,
      2. Centers for Disease Control and Prevention
      . Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009;58(RR-10):1–8pmid:19713882
      OpenUrlPubMed
    22. ↵
      Final estimates for 2009–10 seasonal influenza and influenza A (H1N1) 2009 monovalent vaccination coverage—United States, August 2009 through May, 2010. Available at: www.cdc.gov/flu/professionals/vaccination/coverage_0910estimates.htm. Accessed August 16, 2011
      1. Vogt TM,
      2. Wortley PM
      . Epilogue: school-located influenza vaccination during the 2009–2010 pandemic and beyond. Pediatrics. 2012:129(suppl 2):S107–S109
    • Copyright © 2012 by the American Academy of Pediatrics
    PreviousNext
    Back to top

    Advertising Disclaimer »

    In this issue

    Pediatrics
    Vol. 129, Issue Supplement 2
    1 Mar 2012
    • Table of Contents
    • Index by author
    View this article with LENS
    PreviousNext
    Email Article

    Thank you for your interest in spreading the word on American Academy of Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Evolution of the Pediatric Influenza Vaccination Program in the United States
    (Your Name) has sent you a message from American Academy of Pediatrics
    (Your Name) thought you would like to see the American Academy of Pediatrics web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Request Permissions
    Article Alerts
    Log in
    You will be redirected to aap.org to login or to create your account.
    Or Sign In to Email Alerts with your Email Address
    Citation Tools
    Evolution of the Pediatric Influenza Vaccination Program in the United States
    Kathleen M. Neuzil, Anthony E. Fiore, Richard A. Schieber
    Pediatrics Mar 2012, 129 (Supplement 2) S51-S53; DOI: 10.1542/peds.2011-0737B

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Evolution of the Pediatric Influenza Vaccination Program in the United States
    Kathleen M. Neuzil, Anthony E. Fiore, Richard A. Schieber
    Pediatrics Mar 2012, 129 (Supplement 2) S51-S53; DOI: 10.1542/peds.2011-0737B
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Print
    Download PDF
    Insight Alerts
    • Table of Contents

    Jump to section

    • Article
      • Footnotes
      • References
    • Info & Metrics
    • Comments

    Related Articles

    • No related articles found.
    • PubMed
    • Google Scholar

    Cited By...

    • Impact of a city-wide school-located influenza vaccination program over four years on vaccination coverage, school absences, and laboratory-confirmed influenza: a prospective matched cohort study
    • Every Year Is an Influenza Pandemic for Children: Can We Stop Them?
    • Google Scholar

    More in this TOC Section

    • Part 4: Pediatric Basic and Advanced Life Support 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
    • Pediatric Life Support 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations
    • Part 5: Neonatal Resuscitation 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
    Show more Supplement Articles

    Similar Articles

    Subjects

    • Medical Education
      • Medical Education
    • Infectious Disease
      • Infectious Disease
      • Influenza
    • Journal Info
    • Editorial Board
    • Editorial Policies
    • Overview
    • Licensing Information
    • Authors/Reviewers
    • Author Guidelines
    • Submit My Manuscript
    • Open Access
    • Reviewer Guidelines
    • Librarians
    • Institutional Subscriptions
    • Usage Stats
    • Support
    • Contact Us
    • Subscribe
    • Resources
    • Media Kit
    • About
    • International Access
    • Terms of Use
    • Privacy Statement
    • FAQ
    • AAP.org
    • shopAAP
    • Follow American Academy of Pediatrics on Instagram
    • Visit American Academy of Pediatrics on Facebook
    • Follow American Academy of Pediatrics on Twitter
    • Follow American Academy of Pediatrics on Youtube
    • RSS
    American Academy of Pediatrics

    © 2021 American Academy of Pediatrics